Cover Image

Complementary and alternative medications consumed by patients with head and neck carcinoma$aa pilot study in Germany

Complementary and alternative medicine (CAM) represents a wide range of treatment modalities. CAM products may interact with enzymes, transport proteins, and may therefore influence drug metabolism. The prevalence and patterns of CAM usage among patients with head and neck carcinoma (HNC) are largel...

Full description

Saved in:
Bibliographic Details
Main Authors: Schultz, Johannes D. (Author) , Lammert, Anne (Author) , Thorn, Carsten Volker (Author) , Hörmann, Karl (Author) , Sauter, Alexander (Author)
Format: Article (Journal)
Language:English
Published: 14 Feb 2012
In: Nutrition and cancer
Year: 2012, Volume: 64, Issue: 3, Pages: 377-385
ISSN:1532-7914
DOI:10.1080/01635581.2012.655400
Online Access:Verlag, Volltext: https://doi.org/10.1080/01635581.2012.655400
Get full text
Author Notes:J.D. Schultz, M. Stegmüller, A. Faber, C. Thorn, and K. Hörmann, R. Nowack, A. Sauter
Description
Summary:Complementary and alternative medicine (CAM) represents a wide range of treatment modalities. CAM products may interact with enzymes, transport proteins, and may therefore influence drug metabolism. The prevalence and patterns of CAM usage among patients with head and neck carcinoma (HNC) are largely unknown. This cross-sectional study was designed to document pattern of CAM consumption in patients with HNC. Statistical differences in a significantly higher prevalence of CAM consumption between tumor patients (n = 107) and the control group (n = 112) could be detected. Concerning the frequency of CAM usage, we could document a significant increased consumption of CAM among tumor patients (42.8% vs. 62.6%) especially for herbal teas (P < 0.05), phytotherapy (P < 0.001), supplement products (P < 0.05), and “other” supplements (P < 0.005) comparing the controls. Furthermore a significant influence of female gender and an increased CAM usage could be illustrated. Concerning the knowledge of potential interactions of CAM consumption, only 6.25% of the controls and 19.6% of tumor patients know about possible side effects but only 1.7% of the controls and 6.5% of the tumor patients informed their physician about the CAM usage. The frequency of CAM in head and neck tumor patients seems to be relevant in the supervision of anticancer therapies.
Item Description:Gesehen am 21.08.2020
Physical Description:Online Resource
ISSN:1532-7914
DOI:10.1080/01635581.2012.655400

Similar Items